Last updated: April 22, 2025
Sponsor: St. Jude Children's Research Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Red Blood Cell Disorders
Treatment
N/AClinical Study ID
NCT06646640
HEMLTFU
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Receipt, or planned receipt, of an allogeneic HSCT or infusion of geneticallymodified autologous cells for hemoglobin disorders within 15 years prior toenrollment
Exclusion
Exclusion Criteria:
- Inability or unwillingness of research participant and/or legal guardian/representative to provide written informed consent.
Study Design
Total Participants: 200
Study Start date:
June 01, 2025
Estimated Completion Date:
January 31, 2050
Study Description
Connect with a study center
St. Jude Children's Research Hospital
Memphis, Tennessee 38105
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.